Immuno-Oncology Summit USA


Immuno-Oncology Summit
August 27-31, 2018 I boston, MA, USA

CHI’s Immuno-Oncology Summit became the leading annual meeting focusing on the latest applied research. The comprehensive 5-day, 12-track program covers immunomodulatory antibody engineering and emerging immuno-oncology targets, combination immunotherapy, preclinical and translational IO, predictive biomarkers and companion diagnostics, adoptive T cell therapy, oncolytic viruses and personalized cancer vaccines.

The Immuno-Oncology Summit brings together a unique and international mix of large and medium pharmaceutical and biotech companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers—making the Summit a perfect meeting place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies. Now in its 6th year, the IO Summit consistently delivers a cutting-edge agenda, 600+ senior delegates, and a sold-out exhibit hall.

Please join us in Boston for comprehensive scientific coverage and unparalleled networking opportunities at CHI’s Immuno-Oncology Summit 2018! Learn more at

MabDesign members benefit of 20% reduction during registration. Ask for the code!


August 27-31, 2018


Boston, MA, USA


Cambridge Healthtech Institute